Estrogen not linked to lung cancer mortality in postmenopausal women
August 14th, 2010 - 12:43 pm ICT by ANIWashington, August 14 (ANI): A new study has found that use of estrogen alone did not increase lung cancer mortality in postmenopausal women.
In the Women’s Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with previous hysterectomy taking combined estrogen plus progestin therapy had a statistically significant increase in lung cancer mortality, but not incidence.
Other studies with combined hormone therapy have had conflicting results. But the influence of estrogen alone was unclear.
To determine whether use of estrogen alone was associated with lung cancer incidence and increased lung cancer mortality, Rowan T. Chlebowski, of the Los Angeles Biomedical Research Institute, and colleagues, in a post-hoc analysis examined data from a previous randomized, double-blind, placebo-controlled trial in the WHI.
This trial was conducted in 40 centers in the U.S., in which 10,739 postmenopausal women aged 50-79 years with a hysterectomy were randomly assigned to groups receiving estrogen alone or placebo.
The researchers found there was only one more death from lung cancer in the estrogen group (34 deaths) compared with the placebo group (33 deaths).
Their conclusion was that use of estrogen alone was not associated with lung cancer incidence or death from lung cancer in women with hysterectomies.
The study has been published online August 13 in The Journal of the National Cancer Institute. (ANI)
- Estrogen therapy 'ups kidney stones risk' in postmenopausal women - Oct 12, 2010
- Postmenopausal hormone therapy 'ups breast cancer risk' - Oct 20, 2010
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Combination menopausal hormone therapy ups heart disease risk - Feb 17, 2010
- Anti-estrogen medication 'cuts risk of dying from lung cancer' - Jan 24, 2011
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- Taking tamoxifen to prevent breast cancer can save lives and cut medical costs - Mar 14, 2011
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Use of nitrates increases bone strength: study - Feb 23, 2011
- Hormone replacement therapy 'increases lung cancer risk' - Mar 04, 2010
- Hormone mix may cut breast cancer risk in menopausal women - Oct 20, 2009
- Hormone replacement therapy lessens mortality in younger postmenopausal woman - Oct 29, 2009
- Key culprit in breast cancer metastasis identified - Feb 17, 2011
Tags: biomedical research institute, cancer in women, chlebowski, clinical trials, controlled trial, double blind placebo, estrogen, health initiative, hormone therapy, hysterectomy, journal of the national cancer institute, los angeles biomedical research institute, lung cancer, lung cancer incidence, lung cancer mortality, national cancer institute, placebo group, post hoc analysis, postmenopausal women, whi